UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

Journal of the American College of Cardiology, 2012-08, Vol.60 (8), p.738-746

2012

Volltextzugriff (PDF)

Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care

Pharmacoepidemiology and drug safety, 2016-11, Vol.25 (11), p.1236-1244

2016

Volltextzugriff (PDF)

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort

The American journal of medicine, 2014-04, Vol.127 (4), p.295-302

2014

Volltextzugriff (PDF)

Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis

The Annals of thoracic surgery, 2014-12, Vol.98 (6), p.1989-1997

2014

Volltextzugriff (PDF)

Risk of stroke or systemic embolism in patients with degenerative mitral stenosis with or without atrial fibrillation: A cohort study

International journal of cardiology. Heart & vasculature, 2022-12, Vol.43, p.101126, Article 101126

2022

Volltextzugriff (PDF)

Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence

Journal of the American College of Cardiology, 2016-05, Vol.67 (19), p.2318-2319

2016

Volltextzugriff (PDF)

Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study

BMJ (Online), 2021-05, p.n1135

2021

Volltextzugriff (PDF)

Efficacy and Safety of Dabigatran Etexilate and Warfarin in Real-World Patients With Atrial Fibrillation: A Prospective Nationwide Cohort Study

Journal of the American College of Cardiology, 2013-06, Vol.61 (22), p.2264-2273

2013

Volltextzugriff (PDF)

The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis

PloS one, 2017-11, Vol.12 (11), p.e0188482-e0188482

2017

Volltextzugriff (PDF)

Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey

Europace (London, England), 2017-11, Vol.19 (11), p.1896-1902

2017

Volltextzugriff (PDF)

The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants

The American journal of medicine, 2018-05, Vol.131 (5), p.574.e13-574.e27

2018

Volltextzugriff (PDF)

Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation

The American journal of medicine, 2014-07, Vol.127 (7), p.650-656.e5

2014

Volltextzugriff (PDF)

Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study

Scientific reports, 2016-06, Vol.6 (1), p.27410-27410, Article 27410

2016

Volltextzugriff (PDF)

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)

European journal of preventive cardiology, 2017-01, Vol.24 (1), p.4-40

2017

Volltextzugriff (PDF)

Body Mass Index and Adverse Events in Patients with Incident Atrial Fibrillation

The American journal of medicine, 2013-07, Vol.126 (7), p.640.e9-640.e17

2013

Volltextzugriff (PDF)

Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomes

PloS one, 2014-12, Vol.9 (12), p.e114445

2014

Volltextzugriff (PDF)

A review of risk factors for retinal vein occlusions

Expert review of cardiovascular therapy, 2022-09, Vol.20 (9), p.761-772

2022

Volltextzugriff (PDF)

Thrombocytopenia after COVID-19 vaccination

Journal of autoimmunity, 2021-09, Vol.123, p.102712-102712, Article 102712

2021

Volltextzugriff (PDF)

Atrial flutter and thromboembolic risk: a systematic review

Heart, 2015-09, Vol.101 (18), p.1446-1455

2015

Volltextzugriff (PDF)

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study

Journal of the American Heart Association, 2019-06, Vol.8 (11), p.e011358

2019

Volltextzugriff (PDF)

Myocardial Ischemic Events in ‘Real World’ Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin

The American journal of medicine, 2014-04, Vol.127 (4), p.329-336.e4

2014

Volltextzugriff (PDF)

The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation

Chest, 2014-03, Vol.145 (3), p.559-566

2014

Volltextzugriff (PDF)

Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey

Europace (London, England), 2015-10, Vol.17 (10), p.1596-1600

2015

Volltextzugriff (PDF)

Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies

Cardiovascular therapeutics, 2022-06, Vol.2022, p.1-11

2022

Volltextzugriff (PDF)

Evaluation of Risk Scores as Predictive Tools for Stroke in Patients with Retinal Artery Occlusion: A Danish Nationwide Cohort Study

TH open : companion journal to thrombosis and haemostasis, 2022-10, Vol.6 (4), p.e429-e436

2022

Volltextzugriff (PDF)

1 – 25 von 268

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(228)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(190)
Life Sciences & Biomedicine
(183)
Humans
(172)
Female
(113)
Male
(108)
Cardiovascular System & Cardiology
(103)
Aged
(86)
Cardiac & Cardiovascular Systems
(76)
Middle Aged
(71)
Atrial Fibrillation
(70)
Stroke
(67)
Risk Factors
(66)
Anticoagulants
(50)
Aged, 80 And Over
(47)
Anticoagulants - Therapeutic Use
(44)
Atrial Fibrillation - Complications
(43)
Cohort Studies
(43)
Denmark - Epidemiology
(43)
Atrial Fibrillation - Drug Therapy
(39)
General & Internal Medicine
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Europace
(32)
Journal Of The American College Of Cardiology
(28)
The American Journal Of Medicine
(20)
Chest
(12)
Thrombosis And Haemostasis
(11)
Stroke
(10)
Thrombosis Research
(9)
Circulation
(7)
Expert Review Of Cardiovascular Therapy
(7)
Ugeskrift For Læger
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort

Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis

Risk of stroke or systemic embolism in patients with degenerative mitral stenosis with or without atrial fibrillation: A cohort study

Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence

Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study

Efficacy and Safety of Dabigatran Etexilate and Warfarin in Real-World Patients With Atrial Fibrillation: A Prospective Nationwide Cohort Study

The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis

Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey

The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants

Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation

Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)

Body Mass Index and Adverse Events in Patients with Incident Atrial Fibrillation

Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomes

A review of risk factors for retinal vein occlusions

Thrombocytopenia after COVID-19 vaccination

Atrial flutter and thromboembolic risk: a systematic review

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study

Myocardial Ischemic Events in ‘Real World’ Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin

The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation

Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey

Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies

Evaluation of Risk Scores as Predictive Tools for Stroke in Patients with Retinal Artery Occlusion: A Danish Nationwide Cohort Study

Suchergebnisse filtern